SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: An unfavourable conjunction?
- 8 April 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Cystic Fibrosis
- Vol. 20 (3), e29-e31
- https://doi.org/10.1016/j.jcf.2021.03.024
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The global impact of SARS-CoV-2 in 181 people with cystic fibrosisJournal of Cystic Fibrosis, 2020
- A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosisJournal of Cystic Fibrosis, 2020
- Viral infections trigger exacerbations of cystic fibrosis in adults and children: Figure 1–European Respiratory Journal, 2012
- Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroidsJournal of Cystic Fibrosis, 2012
- Early Pulmonary Inflammation in Infants with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1995